<DOC>
	<DOCNO>NCT00611897</DOCNO>
	<brief_summary>This study test hypothesis extrasynaptic mechanism critically link cognitive effect NMDA antagonism evidence event-related potential ( ERPs ) healthy human .</brief_summary>
	<brief_title>N-acetylcysteine NMDA Antagonist Interactions</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Ages 2145 year ethnic background . Male female . Written informed consent . Exclusion criterion DSMIV diagnosis psychotic , depressive anxiety disorder . A history significant medical/neurological disease cardiac , thyroid , renal , hepatic abnormality , seizure disorder . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , LFTs , TFTs , UA , Utox , Urine pregnancy test ) . History severe allergy multiple adverse drug reaction . Any medication opinion PI could interfere either safety study and/or outcome measure . Any condition opinion investigator would preclude participation study . History major psychiatric disorder first degree relative . Current substance abuse/dependency determine urine toxicology . Current treatment medication psychotropic effect . Treatment benzodiazepine within one week prior test . Current pregnancy , unsatisfactory birth control method report female . Education &lt; 10th grade . IQ &lt; 70 , MR determine Wechsler Abbreviated Scale Intelligence . NonEnglish speaking .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>NMDA</keyword>
	<keyword>glutamate</keyword>
	<keyword>N-acetylcysteine</keyword>
	<keyword>P3</keyword>
</DOC>